2007
DOI: 10.1111/j.1537-2995.2007.01461.x
|View full text |Cite
|
Sign up to set email alerts
|

Recovery of white blood cells and platelets from leukoreduction system chambers of Trima Accel and COBE Spectra plateletpheresis devices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
17
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(19 citation statements)
references
References 6 publications
2
17
0
Order By: Relevance
“…The obtained PBMC yield was in agreement with previous reports that used the Trima Accel device (Néron et al, 2007;Strasser et al, 2007).…”
Section: Discussionsupporting
confidence: 92%
“…The obtained PBMC yield was in agreement with previous reports that used the Trima Accel device (Néron et al, 2007;Strasser et al, 2007).…”
Section: Discussionsupporting
confidence: 92%
“…Research with human material such as PBMCs and immune cells strongly depends on the availability of PBMC sources, which can be a limiting factor, especially if large quantities are required. Whole blood, WBC depletion filters, buffy coats, and LRSCs from the Trima Accel plateletpheresis device are commonly used starting material for PBMC isolation and further usage of different subpopulations . The PBMC source for research purposes is mostly determined by the local blood donation service based on the blood collection systems established in their daily routine.…”
Section: Discussionmentioning
confidence: 99%
“…Those include residual cells from preparative hemapheresis devices for platelet collection such as the Trima Accel device (Terumo BCT) or the AMICUS separator system (Fenwal). It is reported that PBMCs can be gained from the leukoreduction system chamber (LRSC) of the Trima Accel device . The AMICUS separator is a widely used centrifugal separation method using plasma recirculation and elutriation .…”
mentioning
confidence: 99%
“…We recently described apheresis LRS chambers as an efficient source of research‐grade PBMNCs 1 . Strasser and colleagues 2 could not replicate our data and challenged their reproducibility. They are correct that the type and settings of the apheresis machine can influence the number of recovered cells.…”
mentioning
confidence: 89%
“…The reported differences between the results of Strasser and colleagues and ours with the Trima Accel are most likely associated with differences in the volume of processed blood. Strasser and colleagues processed a mean of 3.21 L during 54‐minute platelet (PLT) collections 2 . In contrast, we routinely process a mean of 4.25 L in 80 minutes in plateletpheresis collections (not including triple‐PLT‐product collections, which were not performed with LRS chambers in our report).…”
mentioning
confidence: 90%